Quote:
Originally Posted by scottw
if hurdles were lowered for everyone involved in research and trials, which I believe was the main aspect to get a product to market then they did participate or benefit....they chose not to take research funding but they benefitted in other ways and they needed to step up their game to stay in the race...as a result of warp speed...that's why they call it warp speed...I'm sure if we go back all of you were mocking the idea
|
You're entirely correct. Operation Warp Speed is not only about providing money for research, it consolidates a whole lot of steps and procedures that are normally required for the development of a vaccine in this country. It consolidates a usual 73 month process to completion into a 14 month one.
It reduces a usual 8 month process of R&D + preclinical trials vaccine candidate/s identified, and phase one clinical trials to a 5 month process.
It reduces a usual 44 month process of phase 2 and 3 clinical trials to a 6 month one.
And it reduces a usual 21 month process of manufacturing and distribution to a 3 month one.
Pfizer benefited from the regulatory consolidations and permissions to make this possible, otherwise it would have had to go through the pre Operation Warp Speed lengthy process.
Pfizer agreed to a OWS contract on July 22 and received a fast track designation. They definitely worked under and benefited from Operation Warp Speed even though they didn't accept up front money. And they do have a guaranteed 1.95 billion dollars for delivery of a successful vaccine.
Without some OWS kind of initiative, it would normally take several years to develope a vaccine.